Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Daiichi Sankyo in pursuit of Novartis’ Rydapt with next-generation FLT3 drug
Fierce Biotech
Wed, 05/9/18 - 09:21 am
Tags:
Novartis, Rydapt, acute myeloid leukemia, Daiichi Sankyo, quizartinib
Drugmaker Novartis plays down its deal with Trump’s lawyer, tying it to its former CEO
Marketwatch
Wed, 05/9/18 - 09:18 am
Tags:
Novartis, Donald Trump, Vasant Narasimham, Joe Jimenez, Pharma CEOs
Novartis Paid $400,000 to Trump's Atty Michael Cohen According to Stormy Daniels' Lawyer
CP Wire
Tue, 05/8/18 - 08:44 pm
Tags:
Novartis, Donald Trump
Tue, 05/8/18 - 08:37 pm
Tags:
Novartis
Aurobindo bids $1.6B for Novartis' U.S. dermatology generics: report
Fierce Pharma
Mon, 05/7/18 - 10:53 pm
Tags:
Aurobindo, Novartis, Sandoz, M&A, dermatology, India
FDA approves Novartis combo therapy for aggressive type of thyroid cancer
Reuters
Fri, 05/4/18 - 06:53 pm
Tags:
Novartis, FDA, Tafinlar, Mekinist, anaplastic thyroid cancer
New approval sets up CAR-T showdown for Gilead, Novartis
Biopharma Dive
Wed, 05/2/18 - 10:00 pm
Tags:
Kymriah, Novartis, cell therapy, Yescarta, Gilead Sciences
Eyeing Eylea’s $5B sales, Novartis touts solid 12-week dosing data for its rival RTH258
Endpoints
Mon, 04/30/18 - 09:04 pm
Tags:
Novartis, Regeneron, Eylea, RTH258, wet age-related macular degeneration
4 Huge Pharma Deals in 4 Months Is Just the Beginning
Motley Fool
Sat, 04/28/18 - 12:18 pm
Tags:
M&A, Takeda, Shire, Novartis, AveXis, Sanofi, Bioverativ, Celgene, Juno Therapeutics
First Patient Dosed in Avexis' Phase 3 Trial of AVXS-101 in Pre-Symptomatic Spinal Muscular Atrophy
CP Wire
Wed, 04/25/18 - 10:29 pm
Tags:
AveXis, Novartis, M&A, clinical trials, AVXS-101, gene therapy, spinal muscular atrophy
Novartis CEO Vas Narasimhan is raising the bar on second-gen cancer drug studies
Endpoints
Sat, 04/21/18 - 12:44 pm
Tags:
Novartis, cancer, Pharma CEOs, Vas Narasimhan
Novartis pads case for new MS blockbuster with disease-progression analysis
Fierce Pharma
Sat, 04/21/18 - 12:41 pm
Tags:
Novartis, MS, multiple sclerois, siponimod
Good news, Glaxo: Novartis' Advair copy definitely won't see the market this year
Fierce Pharma
Fri, 04/20/18 - 10:00 am
Tags:
Novartis, GSK, Advair, asthma
[video]Did Novartis Overpay for AveXis?
Motley Fool
Mon, 04/16/18 - 11:34 pm
Tags:
Novartis, AveXis, gene therapy, M&A
Q1 kicks off with J&J, Novartis, Glaxo results
Biopharma Dive
Sun, 04/15/18 - 09:48 pm
Tags:
earnings, JNJ, Novartis, GSK
3 Biotech Stocks That Soared This Week
Motley Fool
Sat, 04/14/18 - 12:37 pm
Tags:
AveXis, Abeona Therapeutics, Spectrum Pharmaceuticals, Novartis, M&A, poziotinib, EB-101
Novartis CEO: How To Create Cheaper Alternatives To The Most Expensive Drugs
Forbes
Thu, 04/12/18 - 11:49 am
Tags:
Novartis, Pharma CEOs, FDA, drug pricing, Vasant Narasimham
Novartis offloads failed cancer drug to Oncology Venture
Fierce Biotech
Wed, 04/11/18 - 09:32 am
Tags:
Novartis, Oncology Venture, dovitinib, kidney cancer, cancer
Physician payments linked to scripts for cancer drugs from Novartis, Pfizer and more: study
Fierce Pharma
Tue, 04/10/18 - 10:30 pm
Tags:
physician payments, Novartis, Pfizer, Bayer, Bristol-Myers Squibb, cancer
Why Did Novartis Spend $9 Billion On Gene Therapy? CEO Says: 'A Journey To Focus On Data And Digital'
Forbes
Mon, 04/9/18 - 03:31 pm
Tags:
Novartis, Vas Narasimhan, M&A, gene therapy, AveXis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.